CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.

The old, boring, ugly, ad-heavy, info-light, promos-a-go-go newsletter that so many of us are used to getting has, in the ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

With two Super Bowl championships, two Super Bowl MVPs, and nearly two decades worth of memories, former New York Giants ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Senate on Thursday adopted an emergency spending bill to fill a nearly $3 billion shortfall in the Department of Veterans ...

Tard's bid to acquire Seven & i faces significant hurdles. Find out why I think ANCTF stock is a buy while SVNDY stock is a ...

Presented by TikTok Europe By SARAH WHEATON with ZOYA SHEFTALOVICH PRESENTED BY Send tips here | Tweet @NicholasVinocur ...

This context suggests that the recent sell-off in certain AI stocks was followed by a justified rebound, as issues appear ...